Symbol
ONCY on Nasdaq
Investment type
Equity - Shares of Stock
Class
Common Stock, no par value
Latest Disclosed Ownership
8.19M shares
Security Ownership
9.6%
Shares, Excluding Options vs Price
Value, Excluding Options

Anson Funds Management LP ownership in ONCOLYTICS BIOTECH INC Common Stock, no par value (ONCY)

2025-02-14 - Anson Funds Management LP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 8.19M shares of ONCOLYTICS BIOTECH INC Common Stock, no par value (ONCY). This represents 9.6% percent ownership of the company.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.